2,4-thiazolidinedione has been researched along with Shock, Septic in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkamhawy, A | 1 |
| Kim, NY | 1 |
| Hassan, AHE | 1 |
| Park, JE | 1 |
| Paik, S | 1 |
| Yang, JE | 1 |
| Oh, KS | 1 |
| Lee, BH | 1 |
| Lee, MY | 1 |
| Shin, KJ | 1 |
| Pae, AN | 1 |
| Lee, KT | 1 |
| Roh, EJ | 1 |
1 other study available for 2,4-thiazolidinedione and Shock, Septic
| Article | Year |
|---|---|
Thiazolidine-2,4-dione-based irreversible allosteric IKK-β kinase inhibitors: Optimization into in vivo active anti-inflammatory agents.
Topics: Allosteric Regulation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultu | 2020 |